Ruikang Biological-B(02179.HK) obtained a supplementary Drug Manufacturing License for recombinant varicella vaccine.

Wisdom Capital News APP, Ruik Bio-B (02179.HK) announced that the company has recently obtained the "Drug Production License" amendment approval issued by the Jiangsu Provincial Drug Administration, adding the production scope of recombinant herpes zoster vaccine (CHO cells) and related adjuvants. This amendment marks a further expansion of the Group's research and production capabilities in the field of preventive biologics, laying a solid foundation for the subsequent marketing registration of drugs.